title: Terpenes arrest parasite development and inhibit biosynthesis of isoprenoids in Plasmodium falciparum.
abstract: Development of new drugs is one of the strategies for malaria control. The biosynthesis of several isoprenoids in Plasmodium falciparum was recently described. Interestingly, some intermediates and final products biosynthesized by this pathway in mammals differ from those biosynthesized in P. falciparum. These facts prompted us to evaluate various terpenes, molecules with a similar chemical structure to the intermediates of the isoprenoids pathway, as potential antimalarial drugs. Different terpenes and S-farnesylthiosalicylic acid were tested on cultures of the intraerythrocytic stages of P. falciparum, and the 50% inhibitory concentrations for each one were found: farnesol, 64 microM; nerolidol, 760 nM; limonene, 1.22 mM; linalool, 0.28 mM; and S-farnesylthiosalicylic acid, 14 microM. All the terpenes tested inhibited dolichol biosynthesis in the trophozoite and schizont stages when [1-(n)-(3)H]farnesyl pyrophosphate triammonium salt ([(3)H]FPP) was used as precursor. Farnesol, nerolidol, and linalool showed stronger inhibitory activity on the biosynthesis of the isoprenic side chain of the benzoquinone ring of ubiquinones in the schizont stage. Treatment of schizont stages with S-farnesylthiosalicylic acid led to a decrease in intensity of the band corresponding a p21(ras) protein. The inhibitory effect of terpenes and S-farnesylthiosalicylic acid on the biosynthesis of both dolichol and the isoprenic side chain of ubiquinones and the isoprenylation of proteins in the intraerythrocytic stages of P. falciparum appears to be specific, because overall protein biosynthesis was not affected. Combinations of some terpenes or S-farnesylthiosalicylic acid tested in this work with other antimalarial drugs, like fosmidomycin, could be a new strategy for the treatment of malaria.
authors.affiliation: Universidade de São Paulo, Av. Professor Lineu Prestes, 1374, CEP 05508-900 São Paulo, Brazil.
authors.forename: Herbert
authors.initials: H
authors.lastname: Rodrigues Goulart
authors.forename: Emília A
authors.initials: EA
authors.lastname: Kimura
authors.forename: Valnice J
authors.initials: VJ
authors.lastname: Peres
authors.forename: Alicia S
authors.initials: AS
authors.lastname: Couto
authors.forename: Fulgencio A
authors.initials: FA
authors.lastname: Aquino Duarte
authors.forename: Alejandro M
authors.initials: AM
authors.lastname: Katzin
mesh_terms: D000818:Animals; D002851:Chromatography, High Pressure Liquid; D002855:Chromatography, Thin Layer; D003864:Depression, Chemical; D004286:Dolichols / Q000096:biosynthesis; D004591:Electrophoresis, Polyacrylamide Gel; D004912:Erythrocytes / Q000469:parasitology; D005204:Farnesol / Q000031:analogs & derivatives* / Q000494:pharmacology; D050356:Lipid Metabolism; D016778:Malaria, Falciparum / Q000469:parasitology; D010963:Plasmodium falciparum / Q000187:drug effects / Q000254:growth & development* / Q000378:metabolism*; D011233:Precipitin Tests; D012459:Salicylates / Q000494:pharmacology; D013729:Terpenes / Q000302:isolation & purification / Q000378:metabolism* / Q000494:pharmacology*; D014451:Ubiquinone / Q000096:biosynthesis
chemical_list: D004286:Dolichols; D012459:Salicylates; D013729:Terpenes; C093323:farnesylthiosalicylic acid; D014451:Ubiquinone; D005204:Farnesol